Chengcheng Li

China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.

Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 15, 2025

Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring.

Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring.

Journal: Molecular cancer
Published: February 07, 2025

Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis.

Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis.

Journal: Heliyon
Published: February 27, 2024

Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).

Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).

Journal: EClinicalMedicine
Published: January 05, 2024

T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis.

T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis.

Journal: iScience
Published: May 25, 2023

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer.

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer.

Journal: Aging
Published: March 04, 2023

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma.

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma.

Journal: iScience
Published: January 06, 2023

Hyperprogressive disease after immune checkpoint inhibitor therapy in a patient with non‑small cell lung cancer who harbors a TGFBR2 mutation: A case report.

Hyperprogressive disease after immune checkpoint inhibitor therapy in a patient with non‑small cell lung cancer who harbors a TGFBR2 mutation: A case report.

Journal: Experimental and therapeutic medicine
Published: December 09, 2022

Asymmetric Dihydroxylation-Based Kinetic Resolution of Allylic Amides Enabled by Noncovalent π-Interactions.

Asymmetric Dihydroxylation-Based Kinetic Resolution of Allylic Amides Enabled by Noncovalent π-Interactions.

Journal: Organic letters
Published: November 28, 2022

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: October 31, 2022

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.

Journal: EBioMedicine
Published: April 29, 2022

Circulating cell-free DNA for cancer early detection.

Circulating cell-free DNA for cancer early detection.

Journal: Innovation (Cambridge (Mass.))
Published: February 14, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026